Translate

Sunday, July 31, 2016

The Globalization of International Trade and Standardization of Anti-bribery and Corruption Laws Have Led to the Enactment of International Whistleblower Laws That Reward International Professionals for Anonymously Exposing Fraud

The Globalization of International Trade and Standardization of Anti-bribery and Corruption Laws Have Led to the Enactment of International Whistleblower Laws That Reward International Professionals for Anonymously Exposing Foreign Corrupt Practices Act Violations Including Illegal Bribes, Supply Chain Fraud, and Accounting Fraud

Through globalization of international trade, there has been a shift in many international manufacturing supply chains. As such, raw material supplies for pharmaceuticals, medical supplies, medical equipment, electronics, and several other regulated products that have traditionally come from the United States and Europe are now coming from China and India. This manufacturing shift has created an environment where adulterated ingredients to pharmaceuticals, medical supplies, and medical devices as well as counterfeit parts for weapons and electronics may be used in the manufacturing of products and can create dangerous and adulterated drugs, medical supplies, and medical devices as well as dangerous and defective weapons, computers, aircraft, and vehicles.

For this reason international professionals are being offered large financial rewards to properly expose supply chain fraud including bribes, accounting fraud, and dangerous regulated products.  Under SEC FCPA whistleblower reward laws, an international professional can report these Foreign Corrupt Practice Act violations anonymously through a lawyer to protect their identity and career from potential retaliation.

The Globalization of the Pharmaceutical Industry

Every year over $4.1 trillion (US dollars) is spent worldwide on health services including approximately $850 billion (US dollars) that is spent in the pharmaceutical market on drugs and medications.  In 2011, it is estimated that global pharmaceutical sales are expected to grow by 5% to 7% to around $880 billion.  This growth in sales is led by the 17 so-called "pharmerging countries," which include China, Brazil, Russia, India, Venezuela, Poland and the Ukraine.  These "pharmerging countries", are forecast to see their pharmaceutical spending grow at a 15% to 17% rate in 2011, to between $170 billion and $180 billion overall.

For more information on Globalization in the Pharmaceutical Industry, please go to the following web pages: Globalization in the Pharmaceutical Industry, Drug Company Bribe Whistleblowers, and Doctors in China Are Needed to Expose Illegal Drug Bribes and Fraudulent Marketing Schemes.

The Globalization of Electronics, Weapons Systems, and Aircraft

Globalization of supply chains in international trade has created a shift in where many component parts are produced.  This shift includes the production of electronic components that are used in aircraft, military weapons systems, computers, medical equipment, and other products that are purchased by the United States government through procurement contracts.  These electronic components were traditionally manufactured in the United States and Europe, but are now being manufactured in China, Mexico, India, and South America.  When these electronic components are fake or substandard parts, false certifications regarding the quality of these electronic components can be the subject of a Qui Tam False Claims Act Whistleblower Reward Lawsuit. These lawsuits encourage whistleblowers including international whistleblowers along the electronic component supply chain to blow the whistle on fake military electronic components, low quality electronic components, and other counterfeit electronic parts.

For more information on Globalization in the Electronics, Weapons Systems, and Aircraft, please go to the following web page: Globalization of Electronics, Weapons Systems, and Aircraft.

Thursday, June 16, 2016

China Drug Company Bribe Scheme Whistleblowers Can Earn Large Financial Rewards By Confidentially Reporting Illegal Bribes Through a Lawyer To The SEC by China Drug Company Bribe Whistleblower Reward Lawyer

China Drug Company Bribe Scheme Whistleblowers Can Earn Large Financial Rewards By Confidentially Reporting Illegal Bribes Through a Lawyer To The SEC by China Drug Company Bribe Whistleblower Reward Lawyer Jason S. Coomer

Under the Foreign Corrupt Practices Act and the SEC Whistleblower Incentive Program, whistleblowers with original and specialized knowledge and evidence of corporate bribery and illegal kickbacks are eligible to recover large economic awards.  By gathering this evidence and going through a lawyer, these whistleblowers can protect their identity through the process and potentially collect large rewards of 10% to 30% of the monetary sanctions including disgorged funds.  In cases where systematic bribery schemes have created large drug company revenues of over $1 billion USD, these rewards can be between $100 million USD and $300 million USD.  For more information on this topic, please go to the following web pages:  Chinese Doctors Are Needed to Expose Drug Bribery Schemes and Expose Drug Company Bribes and Earn Large Rewards.

The Chinese Drug Market Is The Target of Many Multinational Drug Companies  

The Chinese pharmaceutical market is one of the fastest growing drug markets in the world.  To capitalize on this fast growing market several drug companies are offering illegal bribes and other incentives to Chinese doctors in order to increase drug sales in China.  These illegal bribery schemes include paying Chinese doctors and Chinese health officials with gift cards, illegal trips, and slush funds to prescribe specific drugs and influence treatment guidelines.

Some of these bribery schemes are extremely complicated and involve systematic gifts given to doctors through accounting fraud and marketing fraud.  Such marketing schemes are illegal under Chinese law and can be the basis for large SEC Bounty Action Rewards.

China Drug Company Bribe Whistleblower Lawyer Jason Coomer Helping Whistleblowers Report Fraud and Claim Rewards

Jason Coomer, who heads a law firm in Austin, Texas, has a Chinese language website offering assistance to whistleblowers. His office and his co-counsel have received around 50 whistleblower reports from China in the last three years and are now taking eight cases forward to the SEC.

We're talking large multinational corporations with multi-billion dollar contracts each year. The whistleblowers are insiders at the corporations as well as doctors who have witnessed elaborate bribery schemes, he told Reuters in on telephone interview from Texas. He declined to give further details about the cases.
   

Wednesday, June 15, 2016

Chinese Doctors Can Confidentially Expose Drug Company Bribes and Earn Large Financial Rewards

Chinese Doctors Can Confidentially Expose Drug Company Bribes and Earn Large Financial Rewards by China Drug Whistleblower Lawyer Jason Coomer

Doctors and other medical professionals are being offered large financial rewards and whistleblower protections to expose drug company bribes, medical device company bribes, and medical supply company bribes.  These whistleblower protections include being able to file a bounty action through an international whistleblower lawyer in order to protect the medical professional's identity.  For more information on exposing illegal bribes and collecting large rewards, please go to the following web page: Chinese Doctors Can Confidentially Expose Drug Company Bribes.

Drug Company Bribes, Medical Device Company Bribes, and Medical Supply Company Bribes in China Can
Be The Basis For Large Bounty Action Rewards

Every year over $4.1 trillion (US dollars) is spent worldwide on health services including approximately $850 billion (US dollars) that is spent in the pharmaceutical market on drugs and medications. In 2011, it is estimated that global pharmaceutical sales are expected to grow by 5% to
7% to around $880 billion. This growth in sales is led by the 17 so-called "pharmerging countries," which include China, Brazil, Russia, India, Venezuela, Poland, and Ukraine. These "pharmerging countries", are forecast to see their pharmaceutical spending grow at a 15% to 17% rate in 2011, to between $170 billion and $180 billion overall.

It is estimated that approximately 10 to 25% of public health care procurement spending including drug contracts, medicine purchases, and pharmaceutical contracts are lost to corrupt and fraudulent acts. As such, there is an international movement to reward pharmaceutical professionals and health care professionals that expose fraudulent and corrupt practices that cost hundreds of billions of dollars and cost lives. This international movement includes SEC Foreign Corrupt Practices Act Whistleblower Reward Lawsuits and traditional Qui Tam False Claims Act Whistleblower Reward Lawsuits which offer whistleblowers large rewards for properly exposing bribes.  Medical providers with first hand knowledge or evidence of large bribes are encouraged to step forward to properly expose these illegal bribes.

Wednesday, July 15, 2015

Government Contract Bribes Can Be the Basis of International Whistleblower Reward Lawsuits That Pay Large Financial Rewards To Whistleblowers by Government Contract Bribe Whistleblower Reward Lawyer

International Government Contract Bribes Can Be the Basis of International Whistleblower Reward Lawsuits That Pay Large Financial Rewards To Whistleblowers by Government Contract Bribe Whistleblower Reward Lawyer Jason S. Coomer

Government contracts are estimated to be over $10 Trillion each year.  It is estimated that as much as 20% of these government contracts are through illegal bribes, kickbacks, and other illicit payments.  Government contracts include spending on military; public works projects; public health care (pharmaceuticals, medical equipment, & hospitals); ports, transportation, & roads; mining and oil extraction; power grid and stations; education; law enforcement; and sanitation services. 

If you have evidence of a government contract illegal bribery scheme, illegal kickback scheme, or other illicit payment scheme, it can be extremely financially beneficial to expose the corruption through a government contract bribe whistleblower reward lawyer.  The lawyer can protect your identity while reviewing your potential case as well as in some instances obtain a large reward from the SEC.  For more information regarding a government contract whistleblower reward lawsuit, please go to the following web page: Foreign Corrupt Practices Act Goverment Contract Whistleblower Reward Lawsuits.

Saturday, April 12, 2014

International Bribery Lawyer Confidentially Reviews FCPA Bounty Actions for Whistleblowers by International Bribery Lawyer Jason S. Coomer

International Bribery Lawyer Confidentially Reviews Foreign Corrupt Practices Act Bribery Scheme Bounty Actions for International Whistleblowers by International Bribery Lawyer and International Bribery Scheme Bounty Action Lawyer Jason S. Coomer

Under the Foreign Corrupt Practices Act and the new SEC Whistleblower Incentive Program, whistleblowers with original and specialized knowledge and evidence of corporate bribery and illegal kickbacks are eligible to recover large economic awards.  By gathering this evidence and properly reporting international bribery scheme to the SEC through an international bribery lawyer, these whistleblowers can protect their identity through the process and potentially collect large rewards of 10% to 30% of the monetary sanctions obtained through the SEC enforcement action.  These rewards can include disgorged funds or the benefit of the bribery damages which can be in the Billions of dollars. 

If you are aware of an illegal bribe or illegal kickback that was used to secure a large contract, please feel free to submit a confidential inquiry or go to the follow web page for more information: International Bribery Lawyer.

Sunday, February 9, 2014

Expose Russia Olympic Bribes: Olympic Bribes and Construction Bribes Can Be The Basis of Large Whistleblower Rewards

Expose Russia Olympic Bribes: Olympic Bribes and Construction Bribes Can Be The Basis of Large Whistleblower Rewards by International Whistleblower Lawyer Jason S. Coomer

Russian whistleblowers, public officials, business professionals, employees of multinational corporations, and others that have evidence of Russian government corruption are eligible for large whistleblower financial rewards.  Russian government corruption that can be the basis for these
awards include illegal payments for business; bribes for construction contracts; illegal incentives for oil, gas and mineral leases; illegal kickbacks for regulatory approval; and other violations of Foreign
Corrupt Practices Act (FCPA).  Russian whistleblowers and multinational corporation whistleblowers are needed to step up to report illegal corrupt practices and can receive large financial rewards for being the first to properly expose significant Russian government corruption.

If you are aware of a significant Foreign Corrupt Practice Act (FCPA) violation, please feel free to go to the following webpage: Russian Whistleblower Rewards or contact Russian Government Whistleblower  Lawyer, Jason Coomer via e-mail message

Contractor flees Russia after refusing to pay Olympic bribes - CBS News

"A new report by a Russian anti-corruption group says the total cost for the games has soared to about $50 billion -- more than five times as much as the last winter games.  Yet the best place to discover why costs have risen so high may not be among the gleaming new venues, but on a street in a town just outside London, where Valery Morozov, once an Olympic contractor -- now a fugitive -- lives."

"Miscalculated, he said, because the local Olympic organizers told him to add about $30 million
to his bill for various Sochi construction projects, and then pay that money back to them as kickbacks."

"The only one reason for this was their pockets," Morozov said. "There was only one reason." Morozov rebuilt some of the crumbling facilities of the old Sochi resort. The kickbacks, he said, followed a familiar formula. The kickback was about 40 percent of the total contract." 

Saturday, February 8, 2014

Expose Illegal Medical Device, Medical Equipment, and Pharmaceutical Bribes: International Whistleblower Reward Lawyer Jason S. Coomer

The SEC Is Offering Large Rewards To International Whistleblowers That Can Properly Expose Medical Device Bribes, Medical Equipment Bribes, and Pharmaceutical Bribes to Physicians by International Whistleblower Lawyer Jason S. Coomer

International whistleblowers can recover large amounts of money for exposing international pharmaceutical and medical device bribes.  By exposing procurement kickbacks, medicine supply chain bribes, and other violations of the Foreign Corrupt Practices Act, a physician or other whistleblower can not only help expose corruption, but can receive a large reward.  As such, pharmaceutical representatives, international drug executives, government officials, physicians, health care providers, community activists, and other persons, who are the original source of
specialized knowledge of international drug company bribes, international pharmaceutical company illegal kickback schemes, medical device and equipment procurement bribery schemes, and other illicit payments for drug procurement, medical device procurement, and medical equipment contracts.

For more information on a potential Foreign Corrupt Practices Act Whistleblower Reward Lawsuit, please go to the following web page: Medical Device, Medical Equipment, and Pharmaceutical Bribe Lawsuits or please feel free to send an e-mail message to International Whistleblower Reward Lawyer Jason Coomer

SEC.gov | SEC Charges Stryker Corporation With FCPA Violations

An SEC investigation found that Stryker Corporation’s subsidiaries in Argentina, Greece, Mexico, Poland, and Romania made illicit payments totaling approximately $2.2 million that were incorrectly described as legitimate expenses in the company’s books and records.  Descriptions varied from a charitable donation to consulting and service contracts, travel expenses, and commissions.  Stryker made approximately $7.5 million in illicit profits as a result of the improper payments.

Stryker has agreed to pay more than $13.2 million to settle the SEC’s charges.

Johnson & Johnson

The SEC alleges that, since at least 1998, J&J’s subsidiaries paid bribes to public doctors in Greece who selected J&J surgical implants, paid bribes to public doctors and hospital administrators in
Poland who awarded tenders to J&J, and paid bribes to public doctors in Romania to prescribe J&J pharmaceutical products. J&J also paid kickbacks to Iraq in order to obtain contracts under the United Nations Oil for Food Program (“Program”).

J&J has agreed to pay more than $48.6 million in disgorgement and prejudgment interest to settle the SEC’s charges and to pay a $21.4 million fine to the U.S. Department of Justice to settle criminal
charges. A resolution of a related investigation by the United Kingdom Serious Fraud Office is anticipated.

The SEC’s complaint alleges that J&J subsidiaries, employees, and agents paid bribes to public doctors and administrators in Greece, Poland, and Romania. Doctors who ordered or prescribed J&J products were rewarded in a variety of ways, including cash and inappropriate travel. A variety of schemes were used to carry-out the bribery, including the use of slush funds, sham civil contracts with doctors, and off-shore companies in the Isle of Man. A J&J executive was involved in the Greek conduct, and MD&D Poland executives running three business lines oversaw the creation of sham contracts, travel documents, and the creation of slush funds in Poland. The SEC’s complaint also alleges that J&J’s agent paid secret kickbacks to Iraq to obtain nineteen Oil for Food contracts.